These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34650551)
1. Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge. Saito T; Sako Y; Sato-Kaneko F; Hosoya T; Yao S; Lao FS; Shpigelman J; Messer K; Pu M; Shukla NM; Chan M; Chu PJ; Cottam HB; Hayashi T; Carson DA; Corr M Front Immunol; 2021; 12():701445. PubMed ID: 34650551 [TBL] [Abstract][Full Text] [Related]
2. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice. Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768 [TBL] [Abstract][Full Text] [Related]
3. Small Molecule Calcium Channel Activator Potentiates Adjuvant Activity. Saito T; Shukla NM; Sato-Kaneko F; Sako Y; Hosoya T; Yao S; Lao FS; Messer K; Pu M; Chan M; Chu PJ; Cottam HB; Hayashi T; Carson DA; Corr M ACS Chem Biol; 2022 Jan; 17(1):217-229. PubMed ID: 34985883 [TBL] [Abstract][Full Text] [Related]
4. Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection. Sato-Kaneko F; Yao S; Lao FS; Nan J; Shpigelman J; Cheng A; Saito T; Messer K; Pu M; Shukla NM; Cottam HB; Chan M; Molina AJ; Corr M; Hayashi T; Carson DA Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34078669 [TBL] [Abstract][Full Text] [Related]
5. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii. Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837 [TBL] [Abstract][Full Text] [Related]
6. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. Goff PH; Hayashi T; MartĂnez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203 [TBL] [Abstract][Full Text] [Related]
7. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice. Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; LĂșcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709 [TBL] [Abstract][Full Text] [Related]
8. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice. Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats. Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine. Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant. Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188 [TBL] [Abstract][Full Text] [Related]
12. Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine. Dong W; Bhide Y; Marsman S; Holtrop M; Meijerhof T; de Vries-Idema J; de Haan A; Huckriede A Biotechnol J; 2018 Apr; 13(4):e1700645. PubMed ID: 29278302 [TBL] [Abstract][Full Text] [Related]
13. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection. Mirshekar M; Haghighat S; Mousavi Z; Abdolghaffari AH; Yazdi MH Immunol Res; 2024 Jun; 72(3):490-502. PubMed ID: 38383811 [TBL] [Abstract][Full Text] [Related]
14. Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines. Chen C; Zhang C; Li R; Wang Z; Yuan Y; Li H; Fu Z; Zhou M; Zhao L Viruses; 2019 Dec; 11(12):. PubMed ID: 31816996 [TBL] [Abstract][Full Text] [Related]
15. Pickering emulsion-guided monomeric delivery of monophosphoryl lipid A for enhanced vaccination. Du Y; Lv J; Hao Z; Li Z; Song T; Ge H; Wang H; Yu Z; Xie Z; Li D; Liu Y J Control Release; 2024 Oct; 374():39-49. PubMed ID: 39111597 [TBL] [Abstract][Full Text] [Related]
16. Monophosphoryl lipid A directly regulates Th1 cytokine production in human CD4 Komai-Koma M; Ji Y; Cao H; Liu Z; McSharry C; Xu D Immunobiology; 2021 Sep; 226(5):152132. PubMed ID: 34478947 [TBL] [Abstract][Full Text] [Related]
17. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A. Stark RJ; Choi H; Koch SR; Fensterheim BA; Lamb FS; Sherwood ER Clin Sci (Lond); 2016 Mar; 130(6):451-61. PubMed ID: 26669797 [TBL] [Abstract][Full Text] [Related]
19. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection. Baldwin SL; Hsu FC; Van Hoeven N; Gage E; Granger B; Guderian JA; Larsen SE; Lorenzo EC; Haynes L; Reed SG; Coler RN Front Immunol; 2018; 9():295. PubMed ID: 29515589 [TBL] [Abstract][Full Text] [Related]
20. A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV. Poteet E; Lewis P; Li F; Zhang S; Gu J; Chen C; Ho SO; Do T; Chiang S; Fujii G; Yao Q PLoS One; 2015; 10(8):e0136862. PubMed ID: 26312747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]